Identification and characterization of the host protein DNAJC14 as a broadly active Flavivirus replication modulator

PLoS Pathogens

Volumn 7, Issue 1, 2011, Pages

  Yi, Zhigang ^a,b   Sperzel, Lindsey ^a   Nürnberger, Cindy ^a   Bredenbeek, Peter J ^a,c   Lubick, Kirk J ^d   Best, Sonja M ^d   Stoyanov, Cristina T ^a,e   Law, Lok Man J ^a   Yuan, Zhenghong ^b   Rice, Charles M ^a   Macdonald, Margaret R ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b FUDAN UNIVERSITY   (China)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DNAJ; PROTEIN DNAJC14; UNCLASSIFIED DRUG; CHAPERONE; DNAJC14 PROTEIN, HUMAN; FETOPROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; FLAVIVIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; KUNJIN VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; YELLOW FEVER FLAVIVIRUS; ANIMAL; CATTLE; CERCOPITHECUS; HAMSTER; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; PATHOGENICITY; TUMOR CELL LINE; VERO CELL; VIROLOGY; YELLOW FEVER;

ARTHROPODA; BOVINE VIRAL DIARRHEA VIRUS 1; FLAVIVIRIDAE; FLAVIVIRUS; HEPACIVIRUS; HEPATITIS C VIRUS; IXODIDA; LANGAT VIRUS; MAMMALIA; PESTIVIRUS; YELLOW FEVER VIRUS;

ANIMALS; CATTLE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; CRICETINAE; FETAL PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR CHAPERONES; VERO CELLS; VIRUS REPLICATION; YELLOW FEVER; YELLOW FEVER VIRUS;

EID: 79551513993     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1001255     Document Type: Article

References (54)

1. Lindenbach BD, Thiel H-J, Rice CM (2007) Flaviviridae: The Viruses and Their Relication. In: Knipe DM, Howley PM, eds. Fields Virology. Fifth edition. Philadelphia: Lippincott, Williams & Wilkins. pp 1101-1152.
2. Gould EA, Solomon T (2008) Pathogenic flaviviruses. Lancet 371: 500-509.
3. Gubler DJ, Kuno G, Markoff L (2007) Flaviviruses. In: Knipe DM, Howley PM, eds. Fields Virology. Fifth edition. Philadelphia: Lippincott Williams & Wilkins. pp 1153-1252.
4. Mackenzie JS, Gubler DJ, Petersen LR (2004) Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10: S98-109.
5. Sampath A, Padmanabhan R (2009) Molecular targets for flavivirus drug discovery. Antiviral Res 81: 6-15.
6. Cowan S, Hatziioannou T, Cunningham T, Muesing MA, Gottlinger HG, et al. (2002) Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism. Proc Natl Acad Sci U S A 99: 11914-11919.
7. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801-805.
8. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, et al. (2000) HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101: 173-185.
9. Jones CT, Catanese MT, Law LM, Khetani SR, Syder AJ, et al. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol 28: 167-171.
10. Law LM, Albin OR, Carroll JW, Jones CT, Rice CM, et al. (2010) Identification of a dominant negative inhibitor of human zinc finger antiviral protein reveals a functional endogenous pool and critical homotypic interactions. J Virol 84: 4504-4512.
11. Lorenz IC, Marcotrigiano J, Dentzer TG, Rice CM (2006) Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature 442: 831-835.
12. Bredenbeek PJ, Kooi EA, Lindenbach B, Huijkman N, Rice CM, et al. (2003) A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol 84: 1261-1268.
13. Chambers TJ, Grakoui A, Rice CM (1991) Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J Virol 65: 6042-6050.
14. Molenkamp R, Kooi EA, Lucassen MA, Greve S, Thijssen JC, et al. (2003) Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins. J Virol 77: 1644-1648.
15. Franco D, Li W, Qing F, Stoyanov CT, Moran T, et al. (2010) Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development. Vaccine 28: 5676-5685.
16. Stoyanov CT, Boscardin SB, Deroubaix S, Barba-Spaeth G, Franco D, et al. (2010) Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii. Vaccine 28: 4644-4652.
17. Jones CT, Patkar CG, Kuhn RJ (2005) Construction and applications of yellow fever virus replicons. Virology 331: 247-259.
18. Blight KJ, McKeating JA, Rice CM (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014.
19. Guo X, Carroll JW, MacDonald MR, Goff SP, Gao G (2004) The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol 78: 12781-12787.
20. Lindenbach BD, Rice CM (1997) Trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 71: 9608-9617.
21. MacDonald MR, Machlin ES, Albin OR, Levy DE (2007) The zinc finger antiviral protein acts synergistically with an interferon-induced factor for maximal activity against alphaviruses. J Virol 81: 13509-13518.
22. Chambers TJ, McCourt DW, Rice CM (1990) Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera. Virology 177: 159-174.
23. Cristea IM, Williams R, Chait BT, Rout MP (2005) Fluorescent proteins as proteomic probes. Mol Cell Proteomics 4: 1933-1941.
24. Schlesinger JJ, Brandriss MW, Monath TP (1983) Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Virology 125: 8-17.
25. Kummerer BM, Rice CM (2002) Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol 76: 4773-4784.
26. Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, et al. (2008) Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48: 1843-1850.
27. Hall RA, Khromykh AA, Mackenzie JM, Scherret JH, Khromykh TI, et al. (1999) Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1. Virology 264: 66-75.
28. Khromykh AA, Kenney MT, Westaway EG (1998) Trans-Complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells. J Virol 72: 7270-7279.
29. Pletnev AG, Men R (1998) Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc Natl Acad Sci U S A 95: 1746-1751.
30. Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, et al. (2010) The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol 84: 3503-3515.
31. Mitzel DN, Best SM, Masnick MF, Porcella SF, Wolfinbarger JB, et al. (2008) Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity. Virology 381: 268-276.
32. Amberg SM, Rice CM (1999) Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing. J Virol 73: 8083-8094.
33. Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. Am J Hygiene 27: 483-497.
34. Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O'Brien WA, et al. (2000) Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 74: 8358-8367.
35. Cristea IM, Rozjabek H, Molloy KR, Karki S, White LL, et al. (2010) Host factors associated with the Sindbis virus RNA-dependent RNA polymerase: rolefor G3BP1 and G3BP2 in virus replication. J Virol 84: 6720-6732.
36. Alvero AB, Burtness BA, Ercan AG, Sapi E (2004) Improved method for the detection of cytokeratin 19-positive cells in the peripheral blood of breast cancer patients. Lab Invest 84: 658-661.
37. Muller A, Rinck G, Thiel HJ, Tautz N (2003) Cell-derived sequences in the Nterminal region of the polyprotein of a cytopathogenic pestivirus. J Virol 77: 10663-10669.
38. Neill JD, Ridpath JF (2001) Recombination with a cellular mRNA encoding a novel DnaJ protein results in biotype conversion in genotype 2 bovine viral diarrhea viruses. Virus Res 79: 59-69.
39. Rinck G, Birghan C, Harada T, Meyers G, Thiel HJ, et al. (2001) A cellular Jdomain protein modulates polyprotein processing and cytopathogenicity of a pestivirus. J Virol 75: 9470-9482.
40. Lackner T, Muller A, Konig M, Thiel HJ, Tautz N (2005) Persistence of bovine viral diarrhea virus is determined by a cellular cofactor of a viral autoprotease. J Virol 79: 9746-9755.
41. Lackner T, Muller A, Pankraz A, Becher P, Thiel HJ, et al. (2004) Temporal modulation of an autoprotease is crucial for replication and pathogenicity of an RNA virus. J Virol 78: 10765-10775.
42. Lackner T, Thiel HJ, Tautz N (2006) Dissection of a viral autoprotease elucidates a function of a cellular chaperone in proteolysis. Proc Natl Acad Sci U S A 103: 1510-1515.
43. Stokes A, Bauer JH, Hudson NP (1928) Transmission of yellow fever to Macacus rhesus. JAMA 96: 253-254.
44. Bermak JC, Li M, Bullock C, Zhou QY (2001) Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat Cell Biol 3: 492-498.
45. Vos MJ, Hageman J, Carra S, Kampinga HH (2008) Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 47: 7001-7011.
46. Li J, Qian X, Sha B (2009) Heat shock protein 40: structural studies and their functional implications. Protein Pept Lett 16: 606-612.
47. Kampinga HH, Craig EA (2010) The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nat Rev Mol Cell Biol 11: 579-592.
48. Agapov EV, Murray CL, Frolov I, Qu L, Myers TM, et al. (2004) Uncleaved NS2-3 is required for production of infectious bovine viral diarrhea virus. J Virol 78: 2414-2425.
49. Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, et al. (1990) Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A 87: 8898-8902.
50. Welbourn S, Green R, Gamache I, Dandache S, Lohmann V, et al. (2005) Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replication. J Biol Chem 280: 29604-29611.
51. Bick MJ, Carroll JW, Gao G, Goff SP, Rice CM, et al. (2003) Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol 77: 11555-11562.
52. Kelley WL (1998) The J-domain family and the recruitment of chaperone power. Trends Biochem Sci 23: 222-227.
53. Stirling PC, Bakhoum SF, Feigl AB, Leroux MR (2006) Convergent evolution of clamp-like binding sites in diverse chaperones. Nat Struct Mol Biol 13: 865-870.
54. Bukau B, Horwich AL (1998) The Hsp70 and Hsp60 chaperone machines. Cell 92: 351-366.